Evidence map›Paper›PMID 38858227›Full record

Observational studyEuropean journal of pediatrics2024

Pulmonary function and bronchopulmonary dysplasia classification: insights from the Spanish Registry.

Cristina Ramos-Navarro, Manuel Sánchez-Luna, Santiago Pérez-Tarazona, Ester Sanz-López, Elena Maderuelo-Rodriguez, Santiago Rueda-Esteban, Ana Sánchez-Torres, Ana Concheiro-Guisán, Manuel Sánchez-Solís, GEIDIS Research Network

Abstract readObservational StudyMulticenter Study
PubMed Publisher
In one paragraph

Observational study in European journal of pediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Toward precision for bronchopulmonary dysplasia: Moving past current definitions.Journal of perinatology : official journal of the California Perinatal Association · 2026
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Cristina Ramos-NavarroNeonatologist at Neonatology Department, Gregorio Marañón University Hospital, Madrid, Spain. cramosn@salud.madrid.org.
Manuel Sánchez-LunaNeonatologist at Neonatology Department, Gregorio Marañón University Hospital, Madrid, Spain.
Santiago Pérez-TarazonaNeonatologist at Neonatology Department, La Fe University Hospital, Valencia, Spain.
Ester Sanz-LópezNeonatologist at Neonatology Department, Gregorio Marañón University Hospital, Madrid, Spain.
Elena Maderuelo-RodriguezNeonatologist at Neonatology Department, Gregorio Marañón University Hospital, Madrid, Spain.
Santiago Rueda-EstebanPediatric Pulmonologist at Pulmonology Department, San Carlos University Hospital, Madrid, Spain.
Ana Sánchez-TorresNeonatologist at Neonatology Department, La Paz University Hospital, Madrid, Spain.
Ana Concheiro-GuisánNeonatologist at Neonatology Department, Alvaro Cunqueiro University Hospital, Vigo, Spain.
Manuel Sánchez-SolísPediatric Pulmonologist at Pulmonology Department, Virgen Arrixaca University Hospital Murcia, Murcia, Spain.
GEIDIS Research Network

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2016, the Spanish Research Group on Bronchopulmonary Dysplasia (BPD) (GEIDIS) established a national registry with participation of 66 hospitals to collect information on clinical characteristics and long-term outcomes of BPD infants into adulthood. The aim of this observational study is to examine forced spirometry data in early childhood and to assess their correlation with the respiratory support required at 36 weeks postmenstrual age (PMA). The study analyzed data from preterm infants with BPD born between January 2016 and December 2017 who underwent forced spirometry at 5-7 years of age. Statistical analyses were conducted to investigate the relationships between spirometry results, perinatal factors, and the required respiratory support at 36 weeks PMA. The study involved 143 patients with a median gestational age (GA) of 27.3 weeks (range 25.7-28.7) and a median weight of 880 g (range 740-1135). Abnormal spirometry results were observed in 39.2% (56) of the patients. Among patients diagnosed with BPD type 3, those requiring over 30% oxygen at 36 weeks PMA exhibited an increased risk of abnormal spirometry results (OR 4.48; 95% CI 1.11-18.13) compared to those requiring positive pressure with less than 30% oxygen. In addition, this subgroup had a higher risk of developing a restrictive-mixed pattern compared to those with BPD type 1 (OR 10.65; 95% CI 2.06-54.98) and BPD type 2 (OR 6.76; 95% CI 1.09-42.06). No significant differences were found in the incidence of an obstructive pattern between BPD types.      Conclusion: The requirement of more than 30% oxygen at 36 weeks PMA serves as a risk indicator for pulmonary function impairment in school-aged children with BPD. These findings suggest persistent airway and parenchymal injury in this specific patient population, and highlight the importance of careful monitoring to evaluate their long-term effects on lung function. What is Known: • Premature patients with bronchopulmonary dysplasia (BPD) may present abnormalities in pulmonary function tests during school age. However, the predictive accuracy of consensus BPD severity classification remains uncertain. What is New: • The requirement of more than 30% oxygen at 36 weeks postmenstrual age (PMA) indicates a potential risk of pulmonary function impairment in school-aged children with BPD. Additionally, a significant correlation has been observed between a restrictive-mixed pattern with exposure to mechanical ventilation and the development of severe forms of BPD.

Indexed as

Bronchopulmonary DysplasiaRegistriesSpirometryChildChild, PreschoolFemaleGestational AgeHumansInfant, NewbornInfant, PrematureLungMaleSpain

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.